logo

Exhibiting at FOOD INGREDIENTS CHINA 2025

11U20/11V21
NECC (Shanghai)
17 Mar - 19 Mar, 2025

Product Offerings

Products:

Nucleosides: Inosine, Cytidine

Nucleotides: Disodium 5'-inosinate (IMP), Disodium 5'-guanylate (GMP), Adjustable ratio of IMP+GMP mixture (I+G)

Amino Acids and Derivatives: Adenylate uridylic acid, Guanylate inosinic acid

High-end Natural (Enzyme Technology) Food Additives: NA

Nucleotide Series Pharmaceutical Intermediates: NA

Xuchang Foison Biological Technology Company Limited(许昌富森生物科技股份有限公司)is a leading biopharmaceutical and biochemical manufacturing enterprise based in Xuchang, Henan Province, China. With a strong emphasis on nucleotides, nucleosides, and related intermediates, Foison has established itself as a high-tech manufacturer and exporter serving the food, pharmaceutical, and biotechnology sectors worldwide.

Core Business

The core business of Xuchang Foison revolves around the biological fermentation and enzymatic synthesis of nucleotides, nucleosides, and amino acid derivatives. These ingredients are widely used in pharmaceuticals, food flavor enhancers, nutrition fortification, and life science research. The company focuses on integrating upstream microbial fermentation with downstream purification, enabling high-purity, large-scale production.

Product and Service Offerings

  • Nucleosides

    • Inosine: Used in cardiovascular drugs and as a precursor in nucleotide production.
    • Cytidine: A key raw material for the synthesis of cytidine derivatives and nucleotide drugs.
  • Nucleotides

    • Disodium 5'-inosinate (IMP): Widely used in food flavor enhancement and pharmaceutical intermediates.
    • Disodium 5'-guanylate (GMP): A flavor enhancer used in synergy with MSG in food processing.
    • Adjustable IMP+GMP mixtures (I+G): Custom ratios tailored for specific food system requirements.
  • Amino Acids and Derivatives

    • Adenylate uridylic acid and Guanylate inosinic acid: Applied in nucleotide-based drug development and biochemistry.
  • Pharmaceutical Intermediates

    • Nucleotide-derived intermediates used in synthesis of antiviral and immune-regulating drugs.

Specialization and Core USP

Foison’s core USP is its proprietary enzyme-catalyzed and microbial fermentation technology, enabling sustainable, efficient, and scalable production of high-purity nucleotides and nucleosides. Key differentiators include:

  • Advanced bioreactor systems and continuous fermentation lines.
  • Use of green chemistry principles in synthesis and downstream processing.
  • Capability to deliver custom formulations based on I+G ratios and purity requirements.
  • Strong technical collaboration with research institutions and pharmaceutical companies.

Financial Overview

As a privately held and technology-driven enterprise, Foison has shown significant industrial scale and market presence:

  • Annual production capacity exceeds 1,000 metric tons for nucleotide products.
  • Market penetration in over 30 countries, with top clients in Japan, South Korea, India, USA, and EU markets.
  • Recognized as a National High-Tech Enterprise, reflecting investment in innovation and export capability.

Shipment Data

According to data sourced from global trade databases:

  • Regular export shipments of disodium inosinate, guanylate, and nucleosides to leading food ingredient manufacturers and pharmaceutical intermediates suppliers.
  • Verified multi-ton shipments to India, USA, and Germany, with compliance to USP/EP standards.
  • Customized bulk packaging and logistics support for B2B buyers and formulation houses.

Target Market

Xuchang Foison caters to a broad international client base, including:

  • Pharmaceutical companies producing antiviral and nucleotide-based therapeutics.
  • Food & Flavor houses using IMP/GMP as savory enhancers in bouillon, sauces, and seasonings.
  • Biotech firms and research institutions requiring high-purity nucleotides for research and diagnostics.
  • Nutraceutical companies producing fortified food and dietary supplements.

Capabilities

  • Fully integrated production facility spanning tens of thousands of square meters in Henan Province.
  • In-house R&D center with enzyme screening, fermentation optimization, and purification labs.
  • Custom synthesis and OEM production for pharmaceutical intermediates.
  • Comprehensive quality assurance systems covering raw material sourcing to finished product testing.

Certifications and Compliance

Xuchang Foison complies with strict international and domestic regulatory standards, including:

  • ISO 9001:2015 – Quality Management System
  • ISO 22000 – Food Safety Management System
  • FSSC Certification – For food ingredient safety and traceability
  • Kosher and Halal Certifications – Available for food-grade products
  • Compliance with USP, EP, and GB pharmacopeial standards for pharmaceutical intermediates

Customer Testimonials

While specific testimonials are not publicly listed, feedback from global sourcing platforms highlights:

  • Excellent batch-to-batch consistency and high assay purity.
  • Responsive customer support team, particularly for custom documentation and technical COAs.
  • Strong supplier ratings for timely shipment and regulatory compliance readiness.

Major Achievements

  • Recognized as a Top Export-Oriented Enterprise in Xuchang Bio-Industrial Zone.
  • Participation in international food and pharma expos such as CPhI China and FIC.
  • Developed proprietary strains and enzyme systems used in biosynthesis of nucleotide derivatives.
  • Selected for government innovation funding programs focused on green biomanufacturing.

Xuchang Foison Biological Technology Company Limited continues to drive innovation and quality leadership in the nucleotides and nucleosides sector, serving as a trusted partner for companies seeking advanced bioingredients with international compliance and technical support.